medigraphic.com
Coordinación General de Investigación de la Facultad de Salud Pública y Nutrición y la Dirección General de Sistemas e Informática de la Universidad Autónoma de Nuevo León

2001, Number 3

<< Back Next >>

Rev Salud Publica Nutr 2001; 2 (3)

Polimorfismos de la metilentetrahidrofolato reductasa y su asociación con los defectos del tubo neural

Jiménez-Salas Z, Cantú-Martínez PC, Berrún-Castañón LN, González-Martínez BE

Language: Spanish
References: 39
Page:
PDF size: 70.43 Kb.


Text Extraction

No abstract


REFERENCES

  1. Rodríguez-Morán M, JF Guerrero-Romero, M Parra-Quezada, MJ Segura-Pineda, M Levario-Carrillo y EI Sotelo Ham. 1998. Deficiencia de folatos y su asociación con defectos de cierre del tubo neural en el norte de México. Salud Pública Méx. 40: 474-480.

  2. Scott JM, DG Weir & PM Kirke. 1995. Folate and neural tube defects: en Folate in Health and Disease Editado por LB Bailey. Cap. 12 pp 329-360.

  3. Medical Research Council Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 338: 131-137.

  4. Copp AJ, FA Brook, JP Estibeiro, ASW Shum & DL Cockroft. 1990. The embryonic development of mammalian neural tube defects. Progr. Neurobiol 35: 363-403.

  5. Kirke PN, AM Molley, LE Daly, H Burke, DG Weir & JM Scott. 1993. Maternal plasme folate and vitamin B12 are independient risk factors for neural tube defects. Quarterly J. Med. 86: 703-708.

  6. Daly S, Mills JL, AM Molloy, M Conley, YJ Lee, PN Kirke, DG Weir & JM Scott. 1997. Minimum effective dose of folic acid for food fortification to prevent neural tube defects. Lancet 350:1666-1669.

  7. Mills JL, JM McPartlin, PN Kirke, YJ Lee, MR Conley, DG Weir & JM Scott. 1995. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345: 149-151.

  8. Steegers-Theunissen RPM, GHG Boers, FJM Trijbels, JD Finkelstein, HJ Blom, CMG Thomas & GF Borm. 1994. Maternal hyperhomocysteinaemia: a risk factor for neural-tube defects?. Metabolism 43: 1475-1480.

  9. Scott JM, et al., Op. Cit.

  10. Brattstrom L, DEI Wilchen, J Ohrvik & L Brudin. 1998. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease—the result of a meta-analysis. Circulation 98:2520-2526

  11. Chen J, E Giovannucci, K Kelsey, EB Rimm, MJ Stampfer, GA Colditz, D Speigelman, WC Willet & Hunter 1996. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 56: 4862-4864.

  12. Mills JL, et al., Op. Cit.

  13. Steegers-Thusein RPM et al., Op. Cit.

  14. Kirke, 1993, et al., Op. Cit.

  15. van der Put NMJ, EF van der Molen, LAJ Kluijtmans, SG Heil, FJM Trijbels, TKAB Eskes & D van Oppenraaij-Emmerzaal. 1997. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocisteinaemia in neural-tube defects and vascular disease. Q. J. Med. 90: 511-517.

  16. Ramsbotton D, JM Scott, DG Weir, PN Kirke, JL Mills, PM Gallager & AS Whitehead. 1997. Are common mutations of cystathionine--synthase involved in the aetiology of neural tube defects?. Clin Genet 51: 39-42.

  17. van der Put NM, RP Steegers-Theunissen, P Frosst, FJ Trijbels, TK Eskes, LP van den Heuvel, EC Mariman, M den Heyer, R Roxen & HJ. Blom 1995. Mutated methylenehydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.

  18. Frosst P, HJ Blom, R Milos, P Goyette, CA Sheppard, RG Matthews, GJH Boers, M den Heijer, LAJ Kluijtmans, LP van den Heuvel & R Rozen. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahyrofolate reductase. Nat. Genet. 10:111-113.

  19. Kang SS and PW Wong. 1996. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia. Atherosclerosis 119:135-138.

  20. Matthews RG, C Sheppard & C. Goulding 1998. Methylenetetrahydrofolate reductase and methionine synthase: biochemistry and molecular biology. Eur. J. Pediatr. 157(suppl. 2):S54-S59.

  21. Frosst P. et al., Op. Cit.

  22. Kirke PN, JL Mills & AS Whitehead. 1996. Methylenetetrahydrofolate reductase mutation and neural tube defects. Lancet. 348: 1037-1038.

  23. Ou CY, RE Stevenson, VK Brown, CE Schwartz, WP Allen, MJ Khoury, R Rozen, GP Oakley & MJ dams 1996. 5,10-Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am. J. Med. Genet. 63:610-614.

  24. Ma J, MJ Stampfer & CH Hennekens. 1996. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation. 94: 2410-2416.

  25. Frosst P. et al., Op. Cit.

  26. Shaw GM, R. Rozen, RH Finnell, CR Wasserman & EJ Lammer. 1998. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase and risk for spina bifida. Am. J. of Epidemiol. 148: 30-37.

  27. Mutchinick OM. 2000. Polimorfismos moleculares del gen de la MTHFR, ingesta periconcepcional de ácido fólico y defectos del tubo neural. En el Simposio "Defectos del tubo neural: Aspectos epidemiológicos, metabólicos, genéticos y estrategias de prevención." Congreso de Genética y Biomedicina molecular 2000 celebrado en la Cd. de Monterrey N. L.

  28. Perales-Dávila J, L Martínez de Villarreal, H Triana-Saldaña, D Saldívar-Rodríguez, H Barrera-Saldaña, A Rojas-Martínez, R López-Valdez, M Garza-Elizondo, R García-Cavazos, R Valdéz-Leal & J Villarreal-Pérez. 2000. Niveles de ácido fólico, homocisteína y polimorfismo de la enzima MTHFR en pacientes con preeclampsia severa y eclampsia. Memorias del Congreso de Genética y Biomedicina molecular 2000 celebrado en la Cd. de Monterrey N. L. p 53.

  29. Kirke PN. et al., Op. Cit.

  30. Daly S. et al., Op. Cit.

  31. Mills JL et al., Op. Cit.

  32. Steegers-Theunissen et al., Op. Cit.

  33. Ou CY. et al., Op. Cit.

  34. van der Put NM. et al., Op. Cit.

  35. Mornet E, F Muller, A Lenvoise-Furet, AL Delezoide, C Jean-Yves, B Simon-Bouy & JL Serre. 1997. Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum. Genet. 100:512-514.

  36. Shields DC, PN Kirke, JL Mills, D Ramsbottom, AN Molloy, H Burke, DG Weir, JM Scott & AS Whitehead. 1999. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am. J. Hum. Genet. 64: 1045-1055.

  37. Daly S. et al., Op. Cit.

  38. Molloy AM, S Daly, JL Mills, AS Whitehead, D Ramsbottom, MR Conley, DG Weir & JM Scott. 1997. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 349:1591-1593.

  39. van der Put NM, F Gabreels, EM Stevens, JA Smeitink, FJ Trijbels, TK Eskes, LP van den Heuvel & HJ Blom. 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am. J. Hum. Genet. 62:1044-1051.




2020     |     www.medigraphic.com